Chatzisouleiman Ipek, Lialiaris Stergios, Zisoglou Maria, Katsilidou Melina, Katotomichelakis Michail
Otolaryngology - Head and Neck Surgery, Democritus University of Thrace-General University Hospital of Alexandroupolis, Alexandroupolis, GRC.
Cureus. 2022 Jul 25;14(7):e27222. doi: 10.7759/cureus.27222. eCollection 2022 Jul.
Invasive fungal rhinosinusitis (IFRS) typically affects immunocompromised patients. The coronavirus disease 2019 (COVID-19) pandemic may be associated with rare opportunistic fungal infections, probably as a result of immune dysregulation. The COVID-19 infection is characterized by low levels of CD4+T and CD8+T cells which could increase the risk of co-infections from or species. An invasive fungal infection should be suspected in patients who have recently recovered from COVID-19 pneumonia and present with acute destructive rhinosinusitis. There are few cases of IFRS reported in Europe during the pandemic of COVID-19. We describe the case of a 67-year-old patient with diabetes who received corticosteroids during the treatment for COVID-19 infection and was readmitted a few days later for radiologically and clinically suggested IFRS. was identified, and the patient received pharmacological and surgical treatment.
侵袭性真菌性鼻-鼻窦炎（IFRS）通常影响免疫功能低下的患者。2019冠状病毒病（COVID-19）大流行可能与罕见的机会性真菌感染有关，这可能是免疫失调的结果。COVID-19感染的特征是CD4+T细胞和CD8+T细胞水平较低，这可能会增加感染 或 菌种的风险。对于近期从COVID-19肺炎康复且出现急性侵袭性鼻-鼻窦炎的患者，应怀疑有侵袭性真菌感染。在COVID-19大流行期间，欧洲报告的IFRS病例很少。我们描述了一名67岁糖尿病患者的病例，该患者在COVID-19感染治疗期间接受了皮质类固醇治疗，几天后因放射学和临床提示的IFRS再次入院。已鉴定出 ，患者接受了药物和手术治疗。
